Japan's Mitsui Chemicals said on Friday it would shut a 553,000 tons per year naphtha cracker at its Ichihara plant in Chiba, east of Tokyo, for 27 days in July for scheduled maintenance.
The company said it would skip maintenance work this year on its other 455,000 tpy cracker at Osaka plant in western Japan.
Carbon black manufacturer Orion Engineered Carbons plans to rationalize production lines in North and South America and EMEA.
Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.
Clariant has signed a strategic cooperation agreement with Shanghai Electric to jointly foster innovation in sustainable energy solutions.
MSD, known as Merck & Co. in the US and Canada, recently announced it will acquire Verona Pharma, a biopharmaceutical company focused on respiratory diseases, for approximately $10 billion.
Novo Nordisk continues its sizeable manufacturing investments to meet increasing drug demands.
